Feeney John Joseph 4/A
4/A · Vanda Pharmaceuticals Inc. · Filed Jul 20, 2012
Insider Transaction Report
Form 4/AAmended
Feeney John Joseph
Acting Chief Medical Officer
Transactions
- Exercise/Conversion
Common Stock
2012-02-16+4,687→ 16,702 total - Sale
Common Stock
2012-02-16$4.65/sh−4,760$22,152→ 11,942 total - Exercise/Conversion
Common Stock
2012-02-16+7,500→ 12,015 total
Footnotes (5)
- [F1]Each Restricted Stock Unit represents a contingent right to receive a share of the Issuer's common stock.
- [F2]The original Form 4 incorrectly listed the amount of securities beneficially owned following reported transactions as 15,000 shares.
- [F3]The original Form 4 incorrectly listed the amount of securities beneficially owned following reported transactions as 19,687 shares.
- [F4]This transaction was executed in multiple trades at prices ranging from $4.62 to $4.70. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transaction was effected.
- [F5]The original Form 4 incorrectly listed the amount of securities beneficially owned following reported transactions as 14,927 shares.